Related Experiment Video

Updated: Aug 30, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

[Pneumonia in patients from a tuberculosis dispensary]

A E Ditiatkov, L M Mitina, Iu G Grigor'ev

    Problemy Tuberkuleza I Boleznei Legkikh
    |November 6, 2003
    PubMed

    Insights

    Phthisiologists frequently diagnose pneumonia, a condition often misdiagnosed due to missed sputum tests for acid-resistant Mycobacteria. Effective multimodality treatment resolves pneumonia in most tuberculosis hospital patients previously unresponsive to outpatient care.

    Area of Science:

    • Pulmonology
    • Infectious Diseases
    • Microbiology

    Context:

    • Pneumonia presents a diagnostic challenge in tuberculosis settings, accounting for 2.7% of hospital admissions.
    • Diagnostic errors in general hospitals stem from inadequate diagnostic protocols, particularly the omission of sputum analysis for acid-resistant Mycobacteria.
    • This study focuses on patients with pneumonia initially treated ineffectively in outpatient settings.

    Purpose:

    • To analyze the treatment outcomes of pneumonia patients admitted to contagious isolation wards of a tuberculosis hospital.
    • To evaluate the efficacy of multimodality treatment for pneumonia unresponsive to initial outpatient management.

    Summary:

    • The study reviewed 20 pneumonia patients treated in tuberculosis hospital isolation wards after failing outpatient therapy.
    • A comprehensive treatment regimen including broad-spectrum antibiotics (rifampicin, streptomycin), aerosols, and physiotherapy was administered.
    • Nineteen out of twenty patients experienced complete resolution of infiltration and clinical symptoms.

    Impact:

    • Highlights the importance of thorough diagnostic evaluation, including sputum testing for Mycobacteria, in pneumonia cases within tuberculosis hospitals.
    • Demonstrates the effectiveness of a multimodality treatment approach for resolving refractory pneumonia.
    • Suggests improved management strategies for pneumonia in specialized infectious disease settings.

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    Related Concept Videos

    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...